Reboxetine Patent Application for Narcolepsy and Cataplexy Treatment

Sun, 12 Apr 2026 03:20:13 +0000
Intellectual Property

USPTO published patent application US20260097040A1 by Herriot Tabuteau covering methods of treating narcolepsy with cataplexy using reboxetine or esreboxetine. The application includes pharmaceutical compositions and instructions for use in treating the condition. Filing date was December 11, 2025, with publication on April 9, 2026.